X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2139) 2139
Newsletter (76) 76
Book Chapter (15) 15
Book / eBook (1) 1
Book Review (1) 1
Magazine Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1860) 1860
progressive multifocal leukoencephalopathy (1551) 1551
index medicus (977) 977
male (752) 752
virology (712) 712
female (676) 676
adult (653) 653
jc virus (609) 609
leukoencephalopathy, progressive multifocal - virology (575) 575
middle aged (555) 555
jc virus - genetics (501) 501
neurosciences (498) 498
viruses (417) 417
clinical neurology (416) 416
jc virus - isolation & purification (396) 396
immunology (386) 386
infectious diseases (361) 361
natalizumab (331) 331
virus diseases (316) 316
infection (313) 313
leukoencephalopathy, progressive multifocal - diagnosis (286) 286
multiple sclerosis (285) 285
magnetic resonance imaging (282) 282
aged (274) 274
animals (269) 269
dna (265) 265
leukoencephalopathy (251) 251
aids (249) 249
leukoencephalopathy, progressive multifocal - pathology (244) 244
polymerase chain reaction (240) 240
leukoencephalopathy, progressive multifocal (239) 239
neurology (234) 234
cerebrospinal-fluid (233) 233
jc virus - immunology (231) 231
brain - pathology (222) 222
health aspects (220) 220
jc virus - physiology (214) 214
pml (210) 210
disease (202) 202
hiv (199) 199
polyomavirus (197) 197
leukoencephalopathy, progressive multifocal - drug therapy (195) 195
molecular sequence data (193) 193
brain (189) 189
microbiology (185) 185
research (182) 182
polyomavirus infections - virology (181) 181
brain - virology (171) 171
leukoencephalopathy, progressive multifocal - immunology (171) 171
risk factors (169) 169
base sequence (168) 168
bk virus (162) 162
biomedicine (161) 161
central-nervous-system (158) 158
diagnosis (155) 155
dna, viral - genetics (154) 154
leukoencephalopathy, progressive multifocal - complications (152) 152
leukoencephalopathy, progressive multifocal - etiology (150) 150
human-immunodeficiency-virus (148) 148
tumor virus infections - virology (146) 146
infections (141) 141
multiple-sclerosis (141) 141
active antiretroviral therapy (138) 138
hiv infections - complications (138) 138
pathology (137) 137
jc virus - pathogenicity (130) 130
dna, viral - analysis (126) 126
multiple sclerosis - drug therapy (126) 126
prevalence (123) 123
adolescent (122) 122
leukoencephalopathy, progressive multifocal - chemically induced (122) 122
analysis (120) 120
viral load (113) 113
pathogenesis (112) 112
child (111) 111
urine (111) 111
care and treatment (109) 109
virus (109) 109
immunocompromised host (108) 108
jcv (107) 107
lymphocytes (107) 107
central nervous system (103) 103
patients (103) 103
young adult (103) 103
polyoma virus (102) 102
nervous system (98) 98
transplantation (98) 98
cell line (97) 97
therapy (97) 97
treatment outcome (97) 97
deoxyribonucleic acid--dna (96) 96
research article (96) 96
human brain (95) 95
human immunodeficiency virus--hiv (95) 95
human polyomavirus (94) 94
fatal outcome (93) 93
immunohistochemistry (92) 92
patient (91) 91
nervous system diseases (90) 90
replication (90) 90
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2172) 2172
Japanese (39) 39
French (13) 13
Spanish (8) 8
German (7) 7
Hungarian (2) 2
Portuguese (2) 2
Czech (1) 1
Finnish (1) 1
Polish (1) 1
Romanian (1) 1
Russian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2019, Volume 380, Issue 17, pp. 1597 - 1605
Eight patients with progressive multifocal leukoencephalopathy associated with chronic lymphocytic leukemia, HIV infection, lymphoma, or idiopathic lymphopenia received pembrolizumab... 
CIDOFOVIR | MEDICINE, GENERAL & INTERNAL | Immune Reconstitution Inflammatory Syndrome - etiology | Brain - diagnostic imaging | Humans | Middle Aged | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | CD4-Positive T-Lymphocytes - physiology | Viral Load | Adult | Female | Leukoencephalopathy, Progressive Multifocal - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Down-Regulation | Leukoencephalopathy, Progressive Multifocal - drug therapy | Programmed Cell Death 1 Receptor - metabolism | Cerebrospinal Fluid - virology | CD8-Positive T-Lymphocytes - physiology | White Matter - pathology | Magnetic Resonance Imaging | White Matter - diagnostic imaging | JC Virus - isolation & purification | Lymphocyte Count | Aged | Leukoencephalopathy, Progressive Multifocal - diagnostic imaging | Immunologic Factors - therapeutic use | Drug therapy | Leukoencephalopathy | Nuclear magnetic resonance--NMR | PD-1 protein | Laboratories | CD8 antigen | Body weight | Immune clearance | Infections | Cerebrospinal fluid | Progressive multifocal leukoencephalopathy | Disability | Pembrolizumab | Lymphocytes | Peripheral blood | Drug dosages | Movement disorders | Antigens | Immune response | Cytokines | Patients | CD4 antigen | Immune checkpoint | Cell death | Lymphomas | Apoptosis
Journal Article
Journal Article
Journal Article
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 08/2018, Volume 24, Issue 8, pp. 1594 - 1596
Progressive multifocal leukoencephalopathy (PML) is increasingly being reported in patients undergoing immunotherapy... 
IMMUNE | INFECTIOUS DISEASES | INFECTIOUS-DISEASES | THERAPY | EVENTS | IMMUNOLOGY | CANCER | Hodgkin Disease - diagnostic imaging | Hodgkin Disease - virology | Antineoplastic Agents, Immunological - administration & dosage | Hodgkin Disease - pathology | Humans | Middle Aged | Hydrocortisone - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Hodgkin Disease - drug therapy | Female | Leukoencephalopathy, Progressive Multifocal - virology | Nivolumab - adverse effects | Magnetic Resonance Imaging | Antineoplastic Agents, Immunological - adverse effects | Viremia - pathology | Viremia - virology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | JC Virus - isolation & purification | Leukoencephalopathy, Progressive Multifocal - etiology | Viremia - diagnostic imaging | Aged | Leukoencephalopathy, Progressive Multifocal - diagnostic imaging | Leukoencephalopathy, Progressive Multifocal - pathology | Programmed Cell Death 1 Receptor - immunology | Viremia - etiology | Programmed Cell Death 1 Receptor - genetics | Nivolumab - administration & dosage | Care and treatment | Immunotherapy | Leukoencephalopathy, Progressive multifocal | Monoclonal antibodies | Lymphomas | T cells | Health aspects | Apoptosis | immune checkpoint inhibitor | viruses | nivolumab | HIV | progressive multifocal leukoencephalopathy | JC virus | encephalitis | AIDS and other retroviruses | meningtitis | Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab | Research Letter | meningtitis/encephalaitis
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2018, Volume 379, Issue 15, pp. 1443 - 1451
Journal Article